Squeezing Cells:From Serendipitous Discovery to Patient Impact

Armon Sharei PhD '13

Chief Executive Officer & FounderSQZ Biotechnologies

Dr. Sharei is the Chief Executive Officer and Founder of SQZ Biotechnologies (NYSE: SQZ), a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies for patients around the world and has active programs in Oncology, Autoimmune and Infectious Diseases, and other serious conditions. Dr. Sharei received his BS in Chemical Engineering with Honors and Distinction from Stanford University. He earned his PhD in Chemical Engineering from MIT in the laboratories of Professors Klavs Jensen and Robert Langer where he created and implemented the CellSqueeze® technology as a novel method for rapid and flexible cell engineering. Prior to joining SQZ Biotech as CEO, Dr. Sharei completed a Ragon Institute postdoctoral fellowship at Harvard Medical School in the laboratory of Ulrich von Andrian. Dr. Sharei has published 19 peer-reviewed publications and is the inventor on 20 patent families.